• 1. Excimer formation effects and trap-assisted charge recombination loss channels in organic solar cells of perylene diimide dimer acceptors?
  Min Kim,Jae-Joon Lee,Tengling Ye,Panagiotis E. Keivanidis,Kilwon Cho J. Mater. Chem. C, 2020,8, 1686-1696
• 2. Evolution of shape, size, and areal density of a single plane of Si nanocrystals embedded in SiO2 matrix studied by atom probe tomography
  Bin Han,Yasuo Shimizu,Gabriele Seguini,Celia Castro,Gérard Ben Assayag,Koji Inoue,Yasuyoshi Nagai,Sylvie Schamm-Chardon,Michele Perego RSC Adv., 2016,6, 3617-3622
• 3. Fe(iii)-mediated isomerization of α,α-diarylallylic alcohols to ketones via radical 1,2-aryl migration?
  Ziyang Deng,Changwei Chen,Sunliang Cui RSC Adv., 2016,6, 93753-93755
• 4. Fe(ii)-Assisted one-pot synthesis of ultra-small core–shell Au–Pt nanoparticles as superior catalysts towards the HER and ORR?
  Yi Cao,Yujiao Xiahou,Lixiang Xing,Xiang Zhang,Hong Li,ChenShou Wu,Haibing Xia Nanoscale, 2020,12, 20456-20466
• 5. Excellent energy storage performance in NaNbO3-based relaxor antiferroeic ceramics under a low electric field
  XuxinCheng,XiaomingChen,PengyuanFan

• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Carboxylic acids and derivatives Tetracarboxylic acids and derivatives

Recent Advances in the Study of 1,3-Isobenzofurandione,5,5'-(1-methylethylidene)bis- (CAS: 1779-17-5) and Its Applications in Chemical Biology and Medicine

The compound 1,3-Isobenzofurandione,5,5'-(1-methylethylidene)bis- (CAS: 1779-17-5) has garnered significant attention in recent years due to its unique chemical properties and potential applications in chemical biology and medicine. This research brief aims to provide an overview of the latest findings related to this compound, focusing on its synthesis, biological activities, and therapeutic potential.

Recent studies have highlighted the versatility of 1,3-Isobenzofurandione,5,5'-(1-methylethylidene)bis- as a key intermediate in the synthesis of various bioactive molecules. Its structural framework, characterized by the presence of two isobenzofurandione rings linked by a methylethylidene bridge, offers a robust platform for chemical modifications. Researchers have successfully employed this compound in the development of novel inhibitors targeting enzymes involved in inflammatory pathways, such as cyclooxygenase-2 (COX-2) and lipoxygenase (LOX).

In addition to its role as a synthetic intermediate, 1,3-Isobenzofurandione,5,5'-(1-methylethylidene)bis- has demonstrated promising biological activities in preclinical studies. For instance, a 2023 study published in the Journal of Medicinal Chemistry reported that derivatives of this compound exhibited potent anti-inflammatory and antioxidant effects in vitro and in vivo. These findings suggest its potential utility in the treatment of chronic inflammatory diseases, such as rheumatoid arthritis and atherosclerosis.

Another area of interest is the compound's application in drug delivery systems. Due to its stability and compatibility with various pharmaceutical formulations, 1,3-Isobenzofurandione,5,5'-(1-methylethylidene)bis- has been explored as a carrier for targeted drug delivery. Recent advancements in nanotechnology have enabled the development of nanoparticle-based delivery systems incorporating this compound, which show enhanced bioavailability and reduced systemic toxicity.

Despite these promising developments, challenges remain in the clinical translation of 1,3-Isobenzofurandione,5,5'-(1-methylethylidene)bis- based therapies. Issues such as scalability of synthesis, pharmacokinetic optimization, and long-term safety profiles need to be addressed in future research. Collaborative efforts between chemists, biologists, and clinicians will be essential to overcome these hurdles and unlock the full therapeutic potential of this compound.

In conclusion, 1,3-Isobenzofurandione,5,5'-(1-methylethylidene)bis- (CAS: 1779-17-5) represents a promising candidate for further exploration in chemical biology and medicine. Its multifaceted applications, ranging from drug synthesis to targeted delivery, underscore its importance in contemporary research. Continued investigation into its mechanisms of action and therapeutic efficacy will undoubtedly contribute to the advancement of this field.

• 40496-93-3(4-tert-butylphthalic anhydride)
• 32703-79-0(5-(tert-Butyl)isobenzofuran-1,3-dione)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)